Table S3. Recurrence pattern of the early-stage MHCC.

Characteristics	MVI negative	MVI positive	P value
Recurrence rate	20 (54.1%)	27 (90.0%)	0.001
Recurrence <2 year	14 (70.0%)	19 (70.4%)	0.978
Intrahepatic tumor number			1.000
No	1 (5.0%)	1 (3.7%)
Single	13 (65.0%)	18 (66.7%)
Multiple	6 (30.0%)	8 (29.6%)
Extrahepatic recurrence			1.000
Yes	1 (5.0%)	2 (7.4%)
No	19 (95.0%)	25 (92.6%)
Recurrent AFP, ng/mL	82.01±203.14	182.14±314.62	0.554
Treatment			0.847
Re-resection	2 (10.0%)	3 (11.1%)
Ablation	8 (40.0%)	8 (29.6%)
TACE	8 (40.0%)	14 (51.9%)
Others	2 (10.0%)	2 (7.4%)

MHCC, multinodular hepatocellular carcinoma; AFP, alpha fetal protein; TACE, transcatheter arterial chemoembolization.